News
Stockhead on MSN7h
Neurizon’s ALS drug shows safety and extended survival in open-label extension study
Neurizon Therapeutics has reported positive topline results from an open-label extension study of its lead candidate NUZ-001 ...
The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...
Ansa on MSN21h
Italo-US team in ALS diagnosis breakthrough
ROME, AUG 19 - An Italo-US team of scientists have made a breakthrough in the early diagnosis of amyotrophic lateral ...
By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...
Live Science on MSN22h
New brain implant can decode a person's 'inner monologue'
A new brain-computer interface can decode a person's inner speech, which could help people with paralysis communicate.
HealthDay on MSN1d
Scientists develop brain implant to turn thoughts into speech
Stanford University scientists have developed a brain implant designed to "hear" and vocalize words a person with severe ...
Yet another biotech is facing a delay from the FDA as the agency reels from intense staffing cuts. | Yet another biotech is ...
• Key Amyotrophic Lateral Sclerosis Pipeline Therapies: ION363, FB418, SRK-015, RNS60, QRL-201, SAR443820, MN-166, VM202, VRG-50635, Zilucoplan, and others.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback